This bill establishes federal protections and funding to expand access to in vitro fertilization and intrauterine insemination for individuals, military service members, and veterans. It requires most private health plans, Medicaid programs, and Medicare to cover these fertility treatments without imposing higher cost-sharing than other medical services. Additionally, the legislation mandates that the Department of Defense and the Department of Veterans Affairs provide specific fertility preservation and treatment benefits to uniformed service members and eligible veterans. The bill also includes preemption clauses that override state laws restricting these procedures and prohibits discrimination based on marital status, sex, or sexual orientation in the provision of care.
This bill, known as the No Leniency for Fentanyl Dealers Act, aims to increase penalties for trafficking fentanyl and other synthetic opioids while enhancing detection efforts by the U.S. Postal Service. It lowers the quantity thresholds required for federal felony charges and mandates that sentencing guidelines be updated to reflect these stricter penalties. Additionally, the legislation directs the Postmaster General to purchase more chemical screening devices and hire scientists to identify illegal drugs in mail shipments, authorizing $9 million in funding to support these interdiction activities.
This bill requires the Secretary of Defense to submit annual reports to Congress on the progress of redesigning the compensation model for military child care workers. The reports must detail implementation status, expected timelines, and which specific requirements have been met or remain unmet for each branch of the Armed Forces. Additionally, the Secretary must publish these reports on a public website within 30 days of submission to ensure transparency. The legislation does not directly change pay rates or hiring rules but focuses on monitoring and reporting the ongoing changes mandated by a previous law.
The FRONTIER Act establishes a regulatory framework for the largest artificial intelligence developers to manage and disclose risks associated with their most powerful models, known as "frontier models." It requires companies meeting specific revenue and spending thresholds to create public safety frameworks, undergo independent third-party audits, and report incidents or potential harms to the Department of Commerce. The bill also creates a system where the Secretary of Commerce can issue emergency orders to suspend or restrict model development if an imminent catastrophic risk is identified. Additionally, the legislation preempts state laws that impose new obligations on AI developers regarding risk transparency, auditing, and incident reporting to ensure a uniform national approach.
This bill requires the Director of the Consumer Financial Protection Bureau to submit an annual report to the President and Congress regarding the automobile insurance industry. The report must include specific legislative recommendations aimed at lowering the cost of car insurance, along with any other relevant information the Director deems necessary. This requirement takes effect 90 days after the bill is enacted and directly affects the regulatory oversight of the auto insurance sector.
This bill creates a legal exemption from antitrust laws for companies and organizations that share information or coordinate actions to protect against security risks posed by artificial intelligence. Specifically, it allows these entities to exchange data or agree to temporarily delay the release or deployment of AI systems if they believe such steps are necessary to prevent threats like weaponization, attacks on critical infrastructure, or unauthorized access. To qualify for this protection, the organizations must act in good faith, use the shared information solely for security purposes, and submit a written notice to the Department of Justice before implementing any coordinated delays. The law also ensures that details submitted to the government remain confidential and allows the Attorney General to seek court orders against companies that fail to prove their actions were legitimate security measures.
This bill directs the Department of Defense to create designated airspace corridors specifically for testing and training small drones and the systems used to detect or neutralize them. These zones would allow military personnel to safely practice operating various drone technologies, such as sensors and autonomous software, alongside counter-drone measures like electronic warfare and directed energy weapons. The Secretary of Defense must identify suitable locations, potentially building new facilities or using existing ones, while consulting with other government agencies to ensure safety and address regulatory hurdles. Additionally, the bill requires the Pentagon to report to Congress within 90 days of establishing a corridor, providing details on its location, necessary resources, and any agreements with other federal partners.
The Rural Hospital Cybersecurity Enhancement Act directs the Department of Health and Human Services to create a workforce development plan aimed at training cybersecurity professionals specifically for rural hospitals. This strategy requires the Secretary to consult with various federal agencies and healthcare representatives while focusing on partnerships, curriculum development, and identifying local security challenges. Additionally, the bill mandates the publication of free instructional materials and an awareness campaign to help rural hospital staff learn fundamental cybersecurity skills. The legislation does not authorize any new funding, relying instead on existing resources to implement these training and educational initiatives.
This bill would invalidate a final rule issued by the U.S. Fish and Wildlife Service and the National Oceanic and Atmospheric Administration that rescinded the definition of "harm" under the Endangered Species Act. By declaring that the 2026 rule has no force or effect, the legislation aims to restore the previous legal interpretation of how actions can harm protected species. This change directly affects entities subject to the Endangered Species Act by reinstating the broader regulatory framework for protecting endangered and threatened wildlife.
This bill extends the authorization for a Social Security demonstration project aimed at helping disabled individuals return to work until December 31, 2031. It updates the project's rules to allow a longer 120-day waiting period for benefits, adds specific evaluation metrics to track success, and ensures that participants' total income will not decrease due to their involvement in the program. The changes also clarify that administrative costs for the project will be covered by existing Social Security administration funds, while benefits paid to participants will come from the Federal Disability Insurance Trust Fund. These provisions are set to take effect on January 1, 2027, providing a longer timeframe for testing new employment support strategies.
This joint resolution directs the President to remove U.S. Armed Forces from hostilities against Iran that were not authorized by Congress. The bill is based on the constitutional finding that Congress holds the sole power to declare war and notes that no specific authorization exists for the current military operations in Iran. It mandates the withdrawal of troops while allowing the U.S. to continue defensive actions, intelligence sharing, and assistance to allies and citizens affected by the conflict. The measure applies to military engagements initiated since February 28, 2026, without explicit congressional approval.
This bill reauthorizes and expands the Accelerating Access to Critical Therapies for ALS Act through 2031, extending funding for research into treatments for amyotrophic lateral sclerosis. It requires drug manufacturers to share interim clinical trial data with the FDA to better assess the progress of investigational drugs and clarifies that phase 3 clinical trial definitions include combined phase 2/3 trials and planned trials not yet enrolling participants. The legislation also mandates the FDA to publish an updated five-year action plan for ALS and other rare neurodegenerative diseases, including resource needs and coordination strategies with broader disease communities. Additionally, the bill requires the Government Accountability Office to submit a report on the program's implementation four years after enactment.
